ADVFN - Advanced Financial Network.
HOME» NASDAQ » T » TEVA Stock Price » TEVA Stock News

Teva Pharmaceutical Share News

 Teva Pharmaceutical Industries Limited (mm) Stock Price
TEVA Stock Price
 Teva Pharmaceutical Industries Limited (mm) Stock Chart
TEVA Stock Chart
 Teva Pharmaceutical Industries Limited (mm) Stock News
TEVA Stock News
 Teva Pharmaceutical Industries Limited (mm) Company Information
TEVA Company Information
 Teva Pharmaceutical Industries Limited (mm) Stock Trades
TEVA Stock Trades

Teva Pharmaceutical To Switch Listing To NYSE In May

DOW JONES NEWSWIRES Teva Pharmaceutical Industries Ltd. (TEVA, TEVA.TV) said it is moving the listing of its American depositary shares to the New York Stock Exchange from the Nasdaq Global Select Market in May, in the latest round in the stock exchanges' battle for listings. NYSE Euronext (NYX) and Nasdaq OMX Group Inc. (NDAQ) have battled for years to bring in, or poach, listings by offering promotions and other incentives. Much of the recent rivalry between the exchanges has focused on grabbing the listings of newly public companies, including a high-profile crop of technology initial public offerings. Teva, the world's largest maker of generic drugs, recently had a U.S. market capitalization of about $40.5 billion, according to FactSet Research data. The Israel-based company also has been diversifying into brand-name and over-the-counter drugs. Teva last month reported higher fourth-quarter net profit and underscored its aim to reduce its dependence on just a few medicines and markets. Teva's ADSs were down five cents at $43.02 in recent trading. -By Tess Stynes, Dow Jones Newswires; 212-416-2481; Tess.Stynes@dowjones.com

Stock News for Teva Pharmaceutical (TEVA)
DateTimeHeadline
03/23/201509:59:36Teva Migraine Therapy Shows Positive Results in Phase IIb Study
03/02/201509:50:38Correction to Story About Teva Selling Pennsylvania Facility
03/02/201509:18:27Teva Sells Pennsylvania Facility to G&W Laboratories
02/17/201508:33:57Teva to Distribute Eagle Pharmaceutical's Cancer Drug in U.S.
01/26/201508:10:04FDA Rejects Antares' Application for Generic Migraine Drug
08/19/201401:55:00Gamida Cell Announces Investment and Option Agreement with Major...
04/25/201408:57:01Mallinckrodt (MNK) Jumps: Stock Rises 5.1% - Tale of the Tape

Teva Pharmaceutical and other NASDAQ stock quotes are delayed by at least 20 minutes.
All other stock price and quote data is delayed by at least 15 minutes unless otherwise stated. By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2007 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US noad